Liraglutide-associated acute pancreatitis-Reference-Cited by-同舟云学术

Liraglutide-associated acute pancreatitis

Published:2012-03-01 Issue:5 Volume:69 Page:386-389
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Knezevich Emily¹,Crnic Theresa²,Kershaw Scott³,Drincic Andjela⁴

Affiliation:

1. School of Pharmacy and Health Professions, Creighton University, Omaha, NE

2. Aurora Health Care, Milwaukee, WI; at the time of writing she was pharmacy student, School of Pharmacy and Health Professions, Creighton University

3. St. Patrick Hospital/University of Montana Skaggs School of Pharmacy, Missoula, MT; at the time of writing he was pharmacy student, School of Pharmacy and Health Professions, Creighton University

4. University of Nebraska Medical Center, Omaha

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/69/5/386/28360863/ajhp0386.pdf

Reference18 articles.

1. Liraglutide in clinical practice: dosing, safety, and efficacy;Peterson;Int J Clin Pract.,2010

2. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology.,2007

3. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus;Montanya;Clin Ther.,2009

4. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy;Nathan;Diabetes Care.,2009